Rite Aid Corp (RAD)

neg -0.22
Today's Range: 6.71 - 7.04 | RAD Avg Daily Volume: 16,379,800
Last Update: 10/26/16 - 4:01 PM EDT
Volume: 18,274,225
YTD Performance: -10.59%
Open: $7.03
Previous Close: $7.01
52 Week Range: $6.02 - $8.74
Oustanding Shares: 1,052,134,264
Market Cap: 7,396,503,876
6-Month Chart
TheStreet Ratings Grade for RAD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 4 3 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.60 2.50 2.50 2.60
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 46.87
Price Earnings Comparisons:
RAD Sector Avg. S&P 500
46.87 52.10 29.60
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.30% 13.43% 36.91%
Revenue 15.90 0.20 0.07
Net Income -92.20 0.40 0.12
EPS -92.30 0.30 0.10
Earnings for RAD:
Revenue 30.74B
Average Earnings Estimates
Qtr (11/16) Qtr (02/17) FY (02/17) FY (02/18)
Average Estimate $0.05 $0.04 $0.12 $0.25
Number of Analysts 5 4 5 2
High Estimate $0.08 $0.06 $0.21 $0.28
Low Estimate $0.02 $0.02 $0.05 $0.22
Prior Year $0.06 $0.07 $0.23 $0.12
Growth Rate (Year over Year) -20.00% -42.86% -46.09% 101.61%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Prospective deals are hijacking an earnings-based focus on fundamentals.
British American Tobacco's $47 billion offer to purchase Reynolds American could face hurdles from shareholders as well as regulators.
It would block the early November rally you'd expect when this big event is, at last, past us.
Walgreens extends merger deadline with Rite Aid, and Telsa unveils its new product.
For starters, trouble for banks, drugs, energy and M&A.
When bad news is good news.
Oil stocks surge on EIA data, while Rite Aid and Walgreens continue to push their pending deal forward.
These stocks have made U-turns in the past week.

Columnist Conversations

Raytheon is building on Tuesday's impressive breakout.  The defense name is up over 1.25% ahead of tonigh...
Merck had a nice earnings beat on Tuesday which was accompanied by an earlier than expected FDA approval on Ke...
For years Apple was accused of under promise, over deliver --- UPOD as Jim Cramer likes to call it.  Whil...
Market down across the board, as less than optimistic outlook from Apple (AAPL) dampens investor enthusiasm in...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.